Novartis AG
CKIT ANTIBODY DRUG CONJUGATES
Last updated:
Abstract:
The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
4 Jun 2020
Issue date:
31 Dec 2020